Bulgaria vs Greece: Access to anti-retroviral drugs, female
Bulgaria
58.0%
in 2024
Greece
57.0%
in 2024
Bulgaria rank
105th
Greece rank
108th
Access to anti-retroviral drugs, female over time
- Bulgaria
- Greece
How they compare
Bulgaria currently reports 58.0% against 57.0% in Greece, a difference of 1.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Greece ahead.
Bulgaria ranks 105th and Greece ranks 108th of 141 countries.
Greece has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bulgaria | Greece | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.9% | 44.3% | 29.4% | Greece |
| 2010s | 38.4% | 49.7% | 11.3% | Greece |
| 2020s | 53.4% | 55.6% | 2.2% | Greece |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Bulgaria or Greece?
- Bulgaria, at 58.0% against 57.0% in Greece as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Bulgaria and Greece?
- 1.0%, with Bulgaria ahead.
- How many years of comparable data are there for Bulgaria and Greece?
- 25 years are reported by both, from 2000 to 2024.
- How do Bulgaria and Greece rank globally for access to anti-retroviral drugs, female?
- Bulgaria ranks 105th and Greece ranks 108th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.